AGIO: Agios制药

AGIO新闻

• 14:42 Agios: Novo's Sickle Cell Win Changes The PK Activator Game (Rating Downgrade)
• 13:31 Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study
• 16:14 Why Novo Nordisk's Surprise Win Hammered Agios Pharmaceuticals Stock
• 15:12 AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
• 15:12 AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
• 09:47 Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
• 13:36 Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher
• 13:44 Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why
• 15:33 Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss
• 17:30 Truist Securities上调Agios制药目标价至39美元，看好管线进展
• 17:29 Truist Securities raises Agios Pharma stock price target to $39 on pipeline progress
• 14:34 Agios PharmaceuticalsQ4每股收益及营收超出预期
• 14:34 Agios Pharm earnings beat by $0.09, revenue topped estimates
• 12:40 Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates
• 16:28 Agios制药公司将在沙地贫药物推出之际公布财报